Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
AVXT
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.06
N/A
NA
vs NA
Q3.06
N/A
NA
vs NA
Q4.06
N/A
NA
vs NA
Q1.07
N/A
NA
vs NA
Q2.07
N/A
NA
vs NA
Q3.07
N/A
NA
vs NA
Q4.07
N/A
NA
vs NA
Q1.08
N/A
NA
vs NA
Q2.08
N/A
NA
vs NA
Q3.08
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q2.06
+24%
279.2K vs 224.4K
Q3.06
-73%
96.2K vs 349.9K
Q4.06
-34%
212.1K vs 322.6K
Q1.07
-2%
144.5K vs 147.4K
Q2.07
-79%
58.8K vs 279.2K
Q3.07
0%
95.9K vs 96.2K
Q4.07
+50%
318.2K vs 212.1K
Q1.08
-17%
120.1K vs 144.5K
Q2.08
+64%
96.4K vs 58.8K
Q3.08
+108%
199.8K vs 95.9K
Return on Equity
QoQ
Q4.06
-406%
-4.06
vs -0.81
Q1.07
+134%
1.34
vs -4.06
Q2.07
-22%
-0.22
vs 1.34
Q3.07
-37%
-0.37
vs -0.22
Q4.07
-50%
-0.50
vs -0.37
Q1.08
-124%
-1.24
vs -0.50
Q2.08
+750%
7.5
vs -1.24
Q3.08
+90%
0.9
vs 7.5
Institutionnal Ownership
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.
PNK
Relative Strenght
Volume Buzz
-54%
Earning Acce
No
Dist 52w H.
90%